BDBM9142 (2S)-1-[(2S,4R)-4-benzyl-2-hydroxy-4-{[(3S,4S)-3-hydroxy-3,4-dihydro-2H-1-benzopyran-4-yl]carbamoyl}butyl]-4-{2-[5-(pyridin-4-yl)furan-2-yl]propan-2-yl}-N-(2,2,2-trifluoroethyl)piperazine-2-carboxamide::P3 biaryl pyridylfuran analog 3

SMILES: CC(C)(N1CCN(C[C@@H](O)C[C@@H](Cc2ccccc2)C(=O)N[C@@H]2[C@H](O)COc3ccccc23)[C@@H](C1)C(=O)NCC(F)(F)F)c1ccc(o1)-c1ccncc1

InChI Key: InChIKey=DYYJWDSYFDXNOW-FLOLVYIHSA-N

Data: 4 IC50

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 9142   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
HIV-1 Protease (Human immunodeficiency virus type 1)	BDBM9142 ((2S)-1-[(2S,4R)-4-benzyl-2-hydroxy-4-{[(3S,4S)-3-h...) Show SMILES CC(C)(N1CCN(C[C@@H](O)C[C@@H](Cc2ccccc2)C(=O)N[C@@H]2[C@H](O)COc3ccccc23)[C@@H](C1)C(=O)NCC(F)(F)F)c1ccc(o1)-c1ccncc1 |r| Show InChI InChI=1S/C40H46F3N5O6/c1-39(2,35-13-12-33(54-35)27-14-16-44-17-15-27)48-19-18-47(31(23-48)38(52)45-25-40(41,42)43)22-29(49)21-28(20-26-8-4-3-5-9-26)37(51)46-36-30-10-6-7-11-34(30)53-24-32(36)50/h3-17,28-29,31-32,36,49-50H,18-25H2,1-2H3,(H,45,52)(H,46,51)/t28-,29+,31+,32-,36+/m1/s1	PDB MMDB B.MOAD GoogleScholar AffyNet	PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	0.0500	n/a	n/a	n/a	n/a	5.5	30
Merck Research Laboratories					Assay Description Assay of HIV protease inhibition was performed by peptide cleavage using the substrate Val-Ser-Gln-Asn-beta-naphthylalanine*Pro-Ile-Val. Products of ...				Bioorg Med Chem Lett 13: 2573-6 (2003) Article DOI: 10.1016/s0960-894x(03)00474-8 BindingDB Entry DOI: 10.7270/Q2TD9VJ4
					More data for this Ligand-Target Pair
HIV-1 Protease Mutant Q-60C (Human immunodeficiency virus type 1)	BDBM9142 ((2S)-1-[(2S,4R)-4-benzyl-2-hydroxy-4-{[(3S,4S)-3-h...) Show SMILES CC(C)(N1CCN(C[C@@H](O)C[C@@H](Cc2ccccc2)C(=O)N[C@@H]2[C@H](O)COc3ccccc23)[C@@H](C1)C(=O)NCC(F)(F)F)c1ccc(o1)-c1ccncc1 |r| Show InChI InChI=1S/C40H46F3N5O6/c1-39(2,35-13-12-33(54-35)27-14-16-44-17-15-27)48-19-18-47(31(23-48)38(52)45-25-40(41,42)43)22-29(49)21-28(20-26-8-4-3-5-9-26)37(51)46-36-30-10-6-7-11-34(30)53-24-32(36)50/h3-17,28-29,31-32,36,49-50H,18-25H2,1-2H3,(H,45,52)(H,46,51)/t28-,29+,31+,32-,36+/m1/s1	PDB MMDB B.MOAD GoogleScholar AffyNet	PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	0.100	n/a	n/a	n/a	n/a	5.5	30
Merck Research Laboratories					Assay Description Assay of HIV protease inhibition was performed by peptide cleavage using the substrate Val-Ser-Gln-Asn-beta-naphthylalanine*Pro-Ile-Val. Products of ...				Bioorg Med Chem Lett 13: 2569-72 (2003) Article DOI: 10.1016/s0960-894x(03)00475-x BindingDB Entry DOI: 10.7270/Q2PN93V7
					More data for this Ligand-Target Pair
HIV-1 Protease Mutant V-18C (Human immunodeficiency virus type 1)	BDBM9142 ((2S)-1-[(2S,4R)-4-benzyl-2-hydroxy-4-{[(3S,4S)-3-h...) Show SMILES CC(C)(N1CCN(C[C@@H](O)C[C@@H](Cc2ccccc2)C(=O)N[C@@H]2[C@H](O)COc3ccccc23)[C@@H](C1)C(=O)NCC(F)(F)F)c1ccc(o1)-c1ccncc1 |r| Show InChI InChI=1S/C40H46F3N5O6/c1-39(2,35-13-12-33(54-35)27-14-16-44-17-15-27)48-19-18-47(31(23-48)38(52)45-25-40(41,42)43)22-29(49)21-28(20-26-8-4-3-5-9-26)37(51)46-36-30-10-6-7-11-34(30)53-24-32(36)50/h3-17,28-29,31-32,36,49-50H,18-25H2,1-2H3,(H,45,52)(H,46,51)/t28-,29+,31+,32-,36+/m1/s1	MMDB B.MOAD GoogleScholar AffyNet	PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	1.20	n/a	n/a	n/a	n/a	5.5	30
Merck Research Laboratories					Assay Description Assay of HIV protease inhibition was performed by peptide cleavage using the substrate Val-Ser-Gln-Asn-beta-naphthylalanine*Pro-Ile-Val. Products of ...				Bioorg Med Chem Lett 13: 2569-72 (2003) Article DOI: 10.1016/s0960-894x(03)00475-x BindingDB Entry DOI: 10.7270/Q2PN93V7
					More data for this Ligand-Target Pair
HIV-1 Protease Mutant K-60C (Human immunodeficiency virus type 1)	BDBM9142 ((2S)-1-[(2S,4R)-4-benzyl-2-hydroxy-4-{[(3S,4S)-3-h...) Show SMILES CC(C)(N1CCN(C[C@@H](O)C[C@@H](Cc2ccccc2)C(=O)N[C@@H]2[C@H](O)COc3ccccc23)[C@@H](C1)C(=O)NCC(F)(F)F)c1ccc(o1)-c1ccncc1 |r| Show InChI InChI=1S/C40H46F3N5O6/c1-39(2,35-13-12-33(54-35)27-14-16-44-17-15-27)48-19-18-47(31(23-48)38(52)45-25-40(41,42)43)22-29(49)21-28(20-26-8-4-3-5-9-26)37(51)46-36-30-10-6-7-11-34(30)53-24-32(36)50/h3-17,28-29,31-32,36,49-50H,18-25H2,1-2H3,(H,45,52)(H,46,51)/t28-,29+,31+,32-,36+/m1/s1	PDB MMDB B.MOAD GoogleScholar AffyNet	PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	0.300	n/a	n/a	n/a	n/a	5.5	30
Merck Research Laboratories					Assay Description Assay of HIV protease inhibition was performed by peptide cleavage using the substrate Val-Ser-Gln-Asn-beta-naphthylalanine*Pro-Ile-Val. Products of ...				Bioorg Med Chem Lett 13: 2569-72 (2003) Article DOI: 10.1016/s0960-894x(03)00475-x BindingDB Entry DOI: 10.7270/Q2PN93V7
					More data for this Ligand-Target Pair